Lumida
/WVE
⌘K
WAVE Life Sciences Ltd

WAVE Life Sciences Ltd

WVE
$4.59USD-1.71%-0.08 today

MARKET CAP

904.5M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$5
$22

AI Summary

Stalk
TrimMedium

In a Stage 4 decline, WVE remains under sustained seller control with price below all key EMAs and forming sequential lower highs and lower lows. Despite extreme oversold readings and a bearish exhaustion signal, no stable base has formed, and rallies continue to stall on muted volume. The medium-term bias is bearish, and sellers should defer new execution until rallies into resistance rather than selling into diminishing downside momentum.

  • WVE-007 achieved placebo-adjusted 4% total fat and 9.2% visceral reduction at 240 mg dose over three months.
  • Proprietary RNAi/editing technology targets inhibin E, preserving lean mass versus GLP-1 therapies.
  • Q2 2026 net loss rose to $69.4 M from $50.5 M YoY, with R&D up to $51.3 M.
Full analysis →
Insider Trades22 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Feb 26, 2026SellWVEChris Francis66,388$9.66$904.5M-78.88%+0.66%$641.5K+0.00%10b5-1Buy Now
Feb 9, 2026SellWVEChris Francis1,883$13.45$904.5M-78.88%+0.66%$25.3K-0.64%Buy Now
Feb 9, 2026SellWVEChandra Vargeese3,228$13.45$904.5M-78.88%+0.66%$43.4K-0.47%Buy Now
Feb 9, 2026SellWVEKyle MoranChief Financial Officer3,588$13.45$904.5M-78.88%+0.66%$48.3K-0.87%Buy Now
Feb 9, 2026SellWVEPaul BolnoPresident and CEO10,480$13.45$904.5M-78.88%+0.66%$141.0K-0.81%Buy Now
Jan 2, 2026SellWVEChris Francis18,750$9.58$904.5M-78.88%+0.66%$179.7K+0.00%10b5-1Buy Now
Dec 8, 2025BuyWVEKyle MoranChief Financial Officer556,036$10.15$904.5M-78.88%+0.66%$5.6M+2.26%10b5-1Buy Now
Dec 8, 2025SellWVEChris Francis882,062$9.68$904.5M-78.88%+0.66%$8.5M+0.00%10b5-1Buy Now
Aug 22, 2025SellWVEPaul BolnoPresident and CEO217,351$10.10$904.5M-78.88%+0.66%$2.2M-64.24%10b5-1Buy Now
Mar 7, 2025SellWVEPaul BolnoPresident and CEO338,050$6.03$904.5M-78.88%+0.66%$2.0M+0.00%10b5-1Buy Now
Mar 4, 2025BuyWVEChandra Vargeese91,754$2.48$904.5M-78.88%+0.66%$227.5K+33.87%Buy Now
Jan 23, 2025BuyWVEChandra Vargeese46,000$2.48$904.5M-78.88%+0.66%$114.1K+22.51%Buy Now
Nov 25, 2024SellWVEPaul BolnoPresident and CEO100,000$8.74$904.5M-78.88%+0.66%$874.0K+0.00%10b5-1Buy Now
Nov 15, 2024SellWVEPaul BolnoPresident and CEO51,234$14.32$904.5M-78.88%+0.66%$733.7K-19.08%10b5-1Buy Now
Nov 8, 2024SellWVEChris Francis72,000$12.09$904.5M-78.88%+0.66%$870.1K+0.00%10b5-1Buy Now
Oct 16, 2024SellWVEPaul BolnoPresident and CEO90,474$15.00$904.5M-78.88%+0.66%$1.4M-25.20%10b5-1Buy Now
Oct 16, 2024SellWVEChris Francis337,958$9.55$904.5M-78.88%+0.66%$3.2M-25.25%10b5-1Buy Now
Oct 11, 2024BuyWVEKyle MoranChief Financial Officer25,000$2.48$904.5M-78.88%+0.66%$62.0K+126.41%Buy Now
Sep 25, 2024SellWVEKyle MoranChief Financial Officer17,146$9.00$904.5M-78.88%+0.66%$154.3K-46.44%10b5-1Buy Now
Aug 21, 2024SellWVEPaul BolnoPresident and CEO48,366$5.78$904.5M-78.88%+0.66%$279.6K-11.87%10b5-1Buy Now
Jul 22, 2024BuyWVEChandra Vargeese68,210$2.48$904.5M-78.88%+0.66%$169.2K+35.49%Buy Now
Apr 3, 2024SellWVEKyle MoranChief Financial Officer15,630$6.17$904.5M-78.88%+0.66%$96.4K-31.54%10b5-1Buy Now